Evidence map›Paper›PMID 33380878›Full record

ArticleCurrent oncology (Toronto, Ont.)2020

Canadian guidelines on the management of colorectal peritoneal metastases.

A Brind'Amour, P Dubé, J F Tremblay, M L Soucisse, L Mack, A Bouchard-Fortier, J A McCart, A Govindarajan, D Bischof, E Haase and 6 more

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05623787 (Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Recurrence in Patients With High-risk Colorectal and Appendiceal Neoplasms), which is not on this map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05623787 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Recurrence in Patients With High-risk Colorectal and Appendiceal Neoplasms : a Pilot Study

TypeinterventionalSponsorLaval UniversityRan2022 to 2025Enrolled30ConditionsPeritoneal Carcinomatosis, Peritoneal Metastases, Appendix Cancer, Appendix NeoplasmArmsWhole-body diffusion-weighted magnetic resonance imaging
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Observational
  4. Observational
  5. Stage IV Colorectal Cancer Management and Treatment.Journal of clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

A Brind'AmourDepartment of Surgery, Hôpital Maisonneuve-Rosemont, Montreal.
P DubéDepartment of Surgery, Hôpital Maisonneuve-Rosemont, Montreal.
J F TremblayDepartment of Surgery, Hôpital Maisonneuve-Rosemont, Montreal.
M L SoucisseDepartment of Surgery, Hôpital Maisonneuve-Rosemont, Montreal.
L MackDepartment of Surgery, University of Calgary, Calgary, AB.
A Bouchard-FortierDepartment of Surgery, University of Calgary, Calgary, AB.
J A McCartDepartment of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, ON.
A GovindarajanDepartment of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, ON.
D BischofDepartment of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, ON.
E HaaseDepartment of Surgery, University of Alberta, Edmonton, AB.
C GiacomantonioDepartment of Surgery, Dalhousie University, Halifax, NS.
P HebbardDepartment of Surgery, University of Manitoba, Winnipeg, MB.
R YounanDepartment of Surgery, University of Montreal, Montreal, QC.
A MacNeillDepartment of Surgery, University of British Columbia, Vancouver, BC.
C Boulanger-GobeilDepartment of Surgery, chu de Québec-Université Laval, Quebec City.
L SidérisDepartment of Surgery, Hôpital Maisonneuve-Rosemont, Montreal.
Hôpital Maisonneuve-Rosemont · CAMount Sinai Hospital · CAUniversité de Montréal · CAUniversity of Calgary · CACentre Hospitalier de l’Université de Montréal · CADalhousie University · CAUniversité Laval · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Manitoba · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern management of colorectal cancer (crc) with peritoneal metastasis (pm) is based on a combination of cytoreductive surgery (crs), systemic chemotherapy, and hyperthermic intraperitoneal chemotherapy (hipec). Although the role of hipec has recently been questioned with respect to results from the prodige 7 trial, the role and benefit of a complete crs were confirmed, as observed with a 41-month gain in median survival in that study, and 15% of patients remaining disease-free at 5 years. Still, crc with pm is associated with a poor prognosis, and good patient selection is essential. Many questions about the optimal management approach for such patients remain, but all patients with pm from crc should be referred to, or discussed with, a pm surgical oncologist, because cure is possible. The objective of the present guideline is to offer a practical approach to the management of pm from crc and to reflect on the new practice standards set by recent publications on the topic.

Indexed as

Colorectal NeoplasmsHyperthermia, InducedPeritoneal NeoplasmsCanadaCytoreduction Surgical ProceduresHumanscolorectal cancercytoreductive surgeryhyperthermic intraperitoneal chemotherapyperitoneal carcinomatosisPeritoneal metastases

Identifiers

PMID33380878
PMCPMC7755452
OpenAlexW3113720231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.